RT Journal Article
T1 SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A1 de las Penas, R.
A1 Blasco, A.
A1 De Castro, J.
A1 Escobar, Y.
A1 Garcia-Campelo, R.
A1 Gurpide, A.
A1 Lopez-Lopez, R.
A1 Majem, M.
A1 Rodriguez, C. A.
A1 Virizuela, J. A.
K1 Chemotherapy-induced emesis
K1 Antiemetic drugs
K1 Prophylaxis of emesis
K1 SEOM guidelines of antiemetic drugs
K1 Efficacy
K1 Emetogenicity
K1 Palonosetron
K1 Combination
K1 Netupitant
K1 Safety
K1 Nepa
AB Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy. This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.
PB Springer international publishing ag
SN 1699-048X
YR 2016
FD 2016-12-01
LK http://hdl.handle.net/10668/18652
UL http://hdl.handle.net/10668/18652
LA en
DS RISalud
RD Apr 10, 2025